Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
CANCER:
Bladder Cancer
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
‹
Urothelial Cancer (452
)
Urothelial Cancer (452
)
›
Associations
(180)
News
Trials
Search handles
@AdityaBagrodia
@AldoLADETTINO
@AndreaNecchi
@ArndtVogel
@BourlonMaite
@CParkMD
@ChristianRolfo
@DrChoueiri
@DrFelixGuerrero
@DrRanaMcKay
@DrScottTagawa
@DrTylerStewart
@DrYukselUrun
@Dr_Ivanoncologo
@Dr_RaviMadan
@DrewMoghanaki
@ERPlimackMD
@EladSharonMD
@FaltasLab
@GGiannarini
@GIcancerDoc
@JoshMeeks
@KMittalmd
@KeithKow
@KidneyCancerDoc
@KrisWentzelMD
@Latinamd
@LauraBukavinaMD
@LoebStacy
@LujanPomponio
@MPishvaian
@Martin_AngelMD
@MattGalsky
@NagiSaghir
@NazliDizman
@NicholasZaorsky
@NicoleKuderer
@NormandBlais
@OncHahn
@OncoBellmunt
@OncoLucus
@PBlanchardMD
@PGrivasMDPhD
@PLMcCarthyMD
@ParamMariappan
@PaulSargos
@PauloBergerot
@ProfSyedHussain
@Prof_Nick_James
@RPachynski
@RandySweisMD
@RicBertolo
@RohanGarjeMD
@SWilliams_MD
@TapiaJC1
@TiansterZhang
@TomFlaigMD
@TylerSbrt
@UroDocAsh
@VamsiVelcheti
@VedangMurthy
@VivekSubbiah
@WesKassouf
@ZilliThomas
@_ShankarSiva
@aadel_chaudhuri
@achoud72
@alirezaghoreifi
@anandoncologist
@apolo_andrea
@arkhaki
@bergsa83
@brian_rini
@cdanicas
@chulkimMD
@daviesbj
@dawood_findakly
@docpriyamvada
@dralvaropinto
@drenriquegrande
@drgandara
@drlw2309
@duemed
@g_develasco
@jasonlukemd
@jesusanampa
@joanfundi
@jsoriamd
@kmody29
@koshkin85
@malvarezmaestro
@montypal
@mtmdphd
@mtsiatas
@nataliagandur
@navstruck
@neerajaiims
@pcvblack
@pekijammer
@sgilbert1973
@shilpaonc
@sonpavde
@tmprowell
@tompowles1
@weldeiry
Search handles
@AdityaBagrodia
@AldoLADETTINO
@AndreaNecchi
@ArndtVogel
@BourlonMaite
@CParkMD
@ChristianRolfo
@DrChoueiri
@DrFelixGuerrero
@DrRanaMcKay
@DrScottTagawa
@DrTylerStewart
@DrYukselUrun
@Dr_Ivanoncologo
@Dr_RaviMadan
@DrewMoghanaki
@ERPlimackMD
@EladSharonMD
@FaltasLab
@GGiannarini
@GIcancerDoc
@JoshMeeks
@KMittalmd
@KeithKow
@KidneyCancerDoc
@KrisWentzelMD
@Latinamd
@LauraBukavinaMD
@LoebStacy
@LujanPomponio
@MPishvaian
@Martin_AngelMD
@MattGalsky
@NagiSaghir
@NazliDizman
@NicholasZaorsky
@NicoleKuderer
@NormandBlais
@OncHahn
@OncoBellmunt
@OncoLucus
@PBlanchardMD
@PGrivasMDPhD
@PLMcCarthyMD
@ParamMariappan
@PaulSargos
@PauloBergerot
@ProfSyedHussain
@Prof_Nick_James
@RPachynski
@RandySweisMD
@RicBertolo
@RohanGarjeMD
@SWilliams_MD
@TapiaJC1
@TiansterZhang
@TomFlaigMD
@TylerSbrt
@UroDocAsh
@VamsiVelcheti
@VedangMurthy
@VivekSubbiah
@WesKassouf
@ZilliThomas
@_ShankarSiva
@aadel_chaudhuri
@achoud72
@alirezaghoreifi
@anandoncologist
@apolo_andrea
@arkhaki
@bergsa83
@brian_rini
@cdanicas
@chulkimMD
@daviesbj
@dawood_findakly
@docpriyamvada
@dralvaropinto
@drenriquegrande
@drgandara
@drlw2309
@duemed
@g_develasco
@jasonlukemd
@jesusanampa
@joanfundi
@jsoriamd
@kmody29
@koshkin85
@malvarezmaestro
@montypal
@mtmdphd
@mtsiatas
@nataliagandur
@navstruck
@neerajaiims
@pcvblack
@pekijammer
@sgilbert1973
@shilpaonc
@sonpavde
@tmprowell
@tompowles1
@weldeiry
Filter by
Latest
9ms
Tell me about ATM alterations for the treatment of bladder cancer please. (@ClemensLaseur)
9 months ago
ATM (ATM serine/threonine kinase)
9ms
We reported in 2021 p21 & Rb truncating mutations in kidney chromophobe renal cell carcinomas with suspected implications for therapy & pathogenesis. I’m fascinated by p21 & Rb truncating mutations in bladder tumors as well. More research is needed. https://t.co/RrwEr4G0Tv (@weldeiry)
9 months ago
CDKN1A (Cyclin-dependent kinase inhibitor 1A)
9ms
Thrilled to share the stage with @LauraBukavinaMD at #BCANTT23! I'll be delving into 'PPARG the Rogue Conductor's Broken Harmony: How MAPK Pathway Alterations Drive Bladder Cancer Progression,' a new paradigm in bladder cancer. Looking forward to an exciting exchange of ideas! (@RaieBekele)
9 months ago
PPARG (Peroxisome Proliferator Activated Receptor Gamma)
9ms
From science to clinical utility: @Cxbladder Detect - #BladderCancer detection for patients who present with hematuria. Tamer Aboushwareb, MD, PhD @PacificEdgeLtd, Neal Shore, MD, FACS @AtlanticUrology & @JoshMeeks @NM_Urology join to discuss on UroToday > https://t.co/ntpVmbLok6 (@urotoday)
9 months ago
Clinical
|
Cxbladder
9ms
Results from the phase 1b/2 #FIDES02 study: Derazantinib for metastatic #BladderCancer with activating FGFR1/2/3 genetic aberrations. @AndreaNecchi @SanRaffaeleMI joins @CaPsurvivorship @DanaFarber to discuss on UroToday > https://t.co/7XkvtuwvBN (@urotoday)
9 months ago
Metastases
|
FGFR1 (Fibroblast growth factor receptor 1)
|
derazantinib (ARQ 087)
9ms
Insightful discussion with @y_loriot on the randomized #THOR study data that he presented at #ASCO23, confirming efficacy of Erdafitinib in FGFR3-altered platinum-refractory patients with #BladderCancer @ASCO @BladderCancerUS @IBCG_BladderCA @onclive @Uromigos (@koshkin85)
9 months ago
Clinical
|
FGFR3 (Fibroblast growth factor receptor 3)
|
Balversa (erdafitinib)
9ms
Great to sit down recently with the brilliant @apolo_andrea at ANZUP to discuss her perspective on biomarkers in bladder cancer, and promising future treatment strategies https://t.co/LHck0oQ3wj (@WeickhardtOnc)
9 months ago
9ms
Clinical perspective on recurrence mechanisms of non-muscle Invasive #BladderCancer. Join @jteoh_hk @CUHKMedicine and @UroDocAsh @MDAndersonNews as they discuss 5 key mechanisms driving recurrence. Learn more about tackling this challenging cancer here > https://t.co/lBb3VccLTr (@urotoday)
9 months ago
Clinical
9ms
Calling all Urology HCPs - if you're interested in Bladder Cancer Surgery and education, please sign up for free below: 👉 Sign up here : https://t.co/2CK0moivgC 🗓️ 21st & 22nd September 📍 Western General Hospital, Edinburgh @ParamMariappan @KARLSTORZUK @PhotocureASA (@medacPharmaUK)
9 months ago
Clinical • Surgery
9ms
Are there predictive #biomarkers of radiation therapy response in bladder cancer? 🎙️I chat w/ Prof. Ananya Choudoury @achoud72 @TheChristie on the latest research towards personalised care in bladder cancer radiation therapy #ANZUP23 @ANZUPtrials 👉 https://t.co/1ravkqLGDs (@lewisjwau)
9 months ago
9ms
Is there benefit to extended node dissection at time of radical cystectomy for metastatic #bladdercancer? How about excess toxicity? @koshkin85 of @UCSFCancer and Dr. Seth Lerner of @bcmhouston weigh in on SWOG S1011... https://t.co/cwAVU4Di1I (@GUOncologyNow)
9 months ago
Metastases
9ms
Join us on 8/15 for the next HSCO Symposium on #Bladder #Cancer featuring keynote speaker @mouwlab. Stay ahead on the latest updates on novel systemic agents, innovative combined treatments with surgery & radiation & more! Register at: https://t.co/GFGgdHZFtZ (@OSSatACCC)
9 months ago
Surgery
9ms
Predictive and prognostic role of the neutrophil-to-lymphocyte ratio in muscle invasive #BladderCancer treated with neoadjuvant chemotherapy and radical cystectomy. #BeyondTheAbstract with @mvdeimling, @VMS78880496, and @DrShariat > https://t.co/3WVW6evm8Q (@urotoday)
9 months ago
Clinical
9ms
#AgentOrange and #BladderCancer: Insights from a study on 25 million #Veterans. @SWilliams_MD @UTMBUrology and @UroCancerMD @VUMCurology highlight a retrospective cohort study looking at Agent Orange exposure and bladder cancer incidence > https://t.co/HvMTv16a4r (@urotoday)
9 months ago
Retrospective data
9ms
VERY excitingly @BMJOncology have published our @BladderPath trial editorial!! 'Making administrative healthcare systems clinical data the future of clinical trials: lessons from BladderPath' #bladdercancer #data @Prof_Nick_James @mattsydes @CRCTU @MRCCTU https://t.co/EJ8HeERcq4 (@HattieMintz)
9 months ago
Clinical data
9ms
🔘 Resistance to selective FGFR inhibitors in FGFR-driven urothelial cancer #bladdercancer @AACR https://t.co/m6KtQXHHYf (@drenriquegrande)
9 months ago
9ms
Would bipolar ERBT @LamideyNoury replace my favorite 😍 (Thulium-Yag) @samir__lamrini for Bladder tumors, New RCT🤔 & New challenges @KariTikkinen @StefaniaFerret @jteoh_hk @drkemalsarica @drmahmoudabdel @GoumasUrologia @fgomsan @DrParimalGharia @niteshkuro @DrShariat @urotoday (@Mohamedendourol)
9 months ago
9ms
I’m going to hand over to @tompowles1 to talk about bladder cancer top advancements! #ACScancerchat @JournalCancer @BartsECMC (@drfrankiejs)
9 months ago
9ms
Hello everyone! Thanks for joining our discussion on the Top Advancements of the Year in GU cancers in 2022. I’m Frankie, a clinical trial doctor on @tompowles1 team currently undertaking my PhD in wearable devices and circulating biomarkers in bladder cancer💡 (@drfrankiejs)
9 months ago
Clinical
9ms
Pembrolizumab's impact on cystectomy-free survival in BCG unresponsive #BladderCancer from #KEYNOTE057. @GSK_UofT @UofT and @UroDocAsh @MDAndersonNews discuss these promising results and the importance of timely cystectomy to prevent metastatic disease > https://t.co/y646XcpufD (@urotoday)
9 months ago
Metastases
|
Keytruda (pembrolizumab)
9ms
In #BladderCancer, listen to patients and prioritize the quality of initial management. @UroDocAsh @MDAndersonNews discusses the importance of capturing #PatientVoices and patient-reported outcomes. #ReadNow on UroToday > https://t.co/g45bWUT8zV @IBCG_BladderCA @WorldBladderCan (@urotoday)
9 months ago
Clinical • Patient reported outcomes
9ms
Combining CG0070 adenovirus vector with immune checkpoint blockade: Promising results for BCG unresponsive #BladderCancer patients. @UrogerliMD @MoffittNews joins @UroDocAsh @MDAndersonNews discussing promising preliminary results on UroToday > https://t.co/tXAEe9h6FB (@urotoday)
9 months ago
Clinical • Checkpoint inhibition • Checkpoint block
|
cretostimogene grenadenorepvec (CG0070)
9ms
Another great podcast from @declangmurphy @RenuEapen @SimaPorten debating bladder-preserving treatment for muscle-invasise bladder cancer. I hope a discussion about small renal masses will follow🤞 (@amorgado4)
9 months ago
9ms
Long-term follow-up from the #JAVELIN Bladder 100 Trial. @kalasri3 @pmcancercentre joins @UroCancerMD @VUMCurology to discuss these results on UroToday > https://t.co/zaCwLPbslk @EMDSerono (@urotoday)
9 months ago
9ms
@SimaPorten @UCSFUrology was at @ANZUPtrials ASM this week and dropped into GU Cast studio in Melbourne to chat about cystectomy for bladder cancer. How to save more bladders despite high-grade cancer? Cracking episode @RenuEapen @declangmurphy https://t.co/mcgVB7SpdL (@gu_onc)
9 months ago
9ms
Good point! Bladder cancer will be a good example. We will need to know the distribution of EV after IO in the adj (CM-274) and 1L (CM-901) setting. JB100 did not mention EV as a common subseq tx. Same could happen with Bezultifan in RCC. Q is there. A proper method is needed. (@TapiaJC1)
9 months ago
9ms
Carboplatin vs cisplatin-based chemotherapy for lymph node-positive #BladderCancer. #ExpertCommentary @FaltasLab @WCMEnglanderIPM discusses work by von Deimling et al. in @EUplatinum > https://t.co/ntudb1LBtY @mvdeimling @LAUrology_NL (@urotoday)
9 months ago
cisplatin • carboplatin
9ms
Pros and cons of organ-sparing cystectomy in #BladderCancer patients: balancing oncologic and functional outcomes. @ParamMariappan and Maria Carmen Mir join @UroDocAsh to debate on UroToday > https://t.co/lSiJ6h4TAv (@urotoday)
9 months ago
Clinical
9ms
Much enthusiasm to work against limited awareness. Thank you for paving the way for improved care of females with bladder cancer. Definitely needed (@brookmans76)
9 months ago
9ms
Excellent thread + review article @LauraBukavinaMD @PeaceUOrji Should be read by every urologist. The misconception that sexual activity decreases with age in women still impedes proper treatment + #SexualFunction preservation https://t.co/MnB8HxxBbO #BladderCancer https://t.co/XElOJHknlA (@brookmans76)
9 months ago
Clinical • Review
9ms
@Cxbladder Monitor testing to reduce cystoscopy frequency in patients with #BladderCancer. #BeyondTheAbstract with Kevin Li, @CChuMD, Milan Patel, @Uro_Max, @wandering_gu, and @SimaPorten. #ReadNow on UroToday > https://t.co/3B6SPksAcw @UrolOncol @PacificEdgeLtd (@urotoday)
9 months ago
Clinical
|
Cxbladder
9ms
.@PGrivasMDPhD @fredhutch treatment algorithm for metastatic urothelial ca @BladderCancerUS @UCincyMedicine (@VamsiVelcheti)
9 months ago
Metastases
9ms
CtDNA and RCC, promise awaits! Already established in bladder cancer @MattGalsky @tompowles1 but epigenetics May be key. Excellent discussion by @SylvanBacaLab @DanaFarber_GU @kidneycan #KCRS23 @DrChoueiri (@bergsa83)
9 months ago
Circulating tumor DNA
9ms
The "Get Moving Trial" home-based pre and rehabilitation intervention for #MIBC, @BladderCancerUS Translational Clinical Trial Award. @spsutkaMD @UW joins @UroDocAsh @MDAndersonNews to discuss on UroToday > https://t.co/tBlc9Pm9Hf @IBCG_BladderCA @bcan_chisolm @fredhutch (@urotoday)
9 months ago
Clinical
9ms
Check out this insightful video on optimizing care for #BladderCancer in #women with @KSMurrayUro @NYUUrology and @UroDocAsh @MDAndersonNews. A must-watch for all medical professionals and anyone interested in #WomensHealth. Stay informed & empowered! > https://t.co/3ygHIGN1C2 (@urotoday)
9 months ago
Video
9ms
Urothelial cancer is the most common type of #bladdercancer. The EA8192 study is evaluating durvalumab and chemotherapy for patients with high grade upper tract urothelial cancer prior to nephroureterectomy. https://t.co/4dphxuN1s4 cc: @BladderCancerUS @JCensits @PGrivasMDPhD (@eaonc)
9 months ago
Clinical
|
Imfinzi (durvalumab)
9ms
Fascinating discussion on #BladderCancer biomarkers with @UroCancerMD @VUMCurology and Chad Ritch, MD, MBA @UMiamiHealth! From cytology to RNA-based markers, explore the evolving landscape of diagnostic tools and prognostic indicators on UroToday > https://t.co/Cw2wcjSMyL (@urotoday)
9 months ago
Cytology
9ms
looking forward to discuss modern bladder cancer management at #SIU23 @SIU_urology #SIU2023Istanbul in the beautiful city of Istanbul with @slernerbcmedu1 and @siadaneshmand (@CDFankhauser)
9 months ago
9ms
After several negative frontline platinum+ICI clinical trials in #BladderCancer this press release from @bmsnews is an astounding development for cisplatin-eligible patients. Look forward to the data @myESMO @IBCG_BladderCA @WorldBladderCan @BladderCancerUS @urotoday @Uromigos (@koshkin85)
9 months ago
Clinical
|
cisplatin
9ms
.@DanielPetrylak of @SmilowCancer expands on the challenge of designing clinical trials for #bladdercancer today in our roundtable discussion. Do you agree with his concerns? https://t.co/UKnLadII9q (@GUOncologyNow)
9 months ago
Clinical
9ms
Addressing challenges in #BladderCancer surgery: enhancing patient outcomes and preparing for recovery. @spsutkaMD @UW and @zklaassen_md @GACancerCenter discuss #MIBC and the challenges faced by high-risk patients undergoing radical cystectomy. #WatchNow > https://t.co/CmoszlGPDL (@urotoday)
9 months ago
Clinical • Surgery
9ms
Thank you so much @zklaassen_md @urotoday for the opportunity to discuss our work on operationalizing geriatric assessments and developing pragmatic #PREHAB interventions for patients with #bladdercancer!!! @uwurology @fredhutch @HannaHunterMD @BladderCancerUS @CindyLinMD (@spsutkaMD)
9 months ago
Clinical
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login